- In May 2023, Bayer AG introduced a new antibiotic, Ceftiofur, a third-generation cephalosporin designed to treat multiple animal infections such as respiratory, urinary tract, and skin infections. This launch is expected to strengthen Bayer's position in the veterinary antibiotics segment
- In April 2023, Elanco Animal Health announced the launch of Draxxin, a once-daily injectable antibiotic formulated to combat serious gram-negative bacterial infections including E. coli and Klebsiella pneumoniae. The product enhances Elanco’s portfolio for treating life-threatening infections in livestock
- In March 2023, Virbac launched Synulox, a broad-spectrum antibiotic intended for use in treating respiratory, urinary, and skin infections in animals. This product is set to support the company’s growth in the companion and farm animal treatment segments
- In February 2023, Boehringer Ingelheim GmbH unveiled Clavamox, a combination antibiotic containing amoxicillin and clavulanic acid, designed for a wide range of animal infections. The addition of Clavamox enhances Boehringer Ingelheim’s antibiotic treatment options for veterinarians
- In January 2023, Ceva Santé Animale launched Enrofloxacin, a broad-spectrum antibiotic targeting respiratory, urinary, and skin infections in animals. This product reinforces Ceva’s commitment to offering effective antimicrobial solutions for animal health
